0001140361-23-038879.txt : 20230809
0001140361-23-038879.hdr.sgml : 20230809
20230809204112
ACCESSION NUMBER: 0001140361-23-038879
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230809
DATE AS OF CHANGE: 20230809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Amy
CENTRAL INDEX KEY: 0001887865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 231156887
MAIL ADDRESS:
STREET 1: 38 OUTLOOK ROAD
CITY: SWAMPSCOTT
STATE: MA
ZIP: 01907
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0508
4
2023-08-09
0001865494
IO Biotech, Inc.
IOBT
0001887865
Sullivan Amy
C/O IO BIOTECH, INC.
OLE MAALOES VEJ 3
COPENHAGEN
G7
2200
DENMARK
true
Chief Financial Officer
false
Common Stock
2023-08-09
4
A
0
49382
1.9
A
74382
D
Warrants (Right to Buy)
2.47
2023-08-09
4
A
0
49382
0.125
A
2023-08-09
Common Stock
49382
49382
D
These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
2023-08-09